A pilot pharmacokinetic-pharmacodynamic study of benzodiazepine antagonism by flumazenil and aminophylline

Pharmacotherapy

Volumn 16, Issue 6 I, 1996, Pages 1166-1172

  Bonfiglio, Mark F ^a   Fisher Katz, Lynn E ^a   Saltis, Lawrence M ^a   Traeger, Sheldon M ^a   Martin, Bradley R ^a   Nackes, Nicholas A ^a   Perkins, Thomas A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; FLUMAZENIL; MIDAZOLAM; THEOPHYLLINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; ELECTROENCEPHALOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SEDATION;

ADULT; AMINOPHYLLINE; ANTI-ANXIETY AGENTS; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DRUG ANTAGONISM; ELECTROENCEPHALOGRAPHY; FLUMAZENIL; GABA MODULATORS; HALF-LIFE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDAZOLAM; PHOSPHODIESTERASE INHIBITORS;

EID: 0029852485     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Karavokiros KA, Tsipis GB. Flumazenil: a benzodiazepine antagonist. DICP Ann Pharmacother 1990;24:976-81.
2. Bonfiglio MF, Dasta JF. Clinical significance of the benzodiazepine-theophylline interaction. Pharmacotherapy 1991;11:85-7.
3. Segev S, Rehavi M, Rubinstein E. Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor. Antimicrob Agents Chemother 1988;32:1624-26.
4. Niemand D. Adenosine in the inhibition of diazepam sedation by aminophylline. ACTA Anaesthesiol Scand 1986;30:493-5.
5. Koopmans R, Dingemanse J, Danhof M, Horsten GPM, vanBoxtel CJ. Pharmacokinetic-pharmacodynamic modeling of midazolam effects on the human central nervous system. Clin Pharmacol Ther 1988;44:14-22.
6. Greenblatt DJ, Ehrenberg BL, Gunderman J, et al. Pharmacokinetic and encephalographic study of intravenous diazepam, midazolam, and placebo. Clin Pharmacol Ther 1989;45:356-65.
7. Breimer LTM, Hennis PJ, Burm AGL, et al. Quantification of the EEG effect of midazolam by aperiodic analysis in volunteers: Pharmacokinetic/pharmacodynamic modelling. Clin Pharmacokinet 1990;18:245-53.
8. Breimer LTM, Burm AGL, Danhof M, et al. Pharmacokinetic-pharmacodynamic modelling of the interaction between flumazenil and midazolam in volunteers by aperiodic analysis. Clin Pharmacokinet 1991;20:497-508.
9. Marrosu F, Marachi A, DeMartino MR, Saba G, Gessa GL. Aminophylline antagonizes diazepam-induced anesthesia and EEG changes in humans. Psychopharmacology 1985; 85:69-70.
10. Fisher LE, Perch S, Bonfiglio MF, Geers S. Simultaneous determination of midazolam and flumazenil concentrations in human plasma by gas chromatography. J Chromatography 1995;665:217-21.
11. Roca DJ, Schiller GD, Friedman L, et al. Gamma-aminobutyric acid A receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines. Molecular Pharmacology 1990;37:701-9.
12. Allonen H, Zeigler G, Klotz U. Midazolam kinetics. Clin Pharmacol Ther 1981;30:653.
13. Klotz U, Duka T, Dorow R, Doenicke A. Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15-1788. Br J Clin Pharmacol 1985;19:95-8.
14. Hendeles L, Massanari M, Weinberger M. Theophylline. In: Evans WE, Shentag JJ, Jusko WJ, eds. Clinical Pharmacokinetics, 2nd ed. Spokane WA: Applied Therapeutics, 1986:1105-68.
15. Shafer A, Doze Va, White PF. Pharmacokinetic variability of midazolam infusion in critically ill patients. Crit Care Med 1990;18:1039-41.